<DOC>
	<DOCNO>NCT01187498</DOCNO>
	<brief_summary>The primary purpose project evaluate effectiveness behavioral treatment compare standard drug therapy symptom OAB male veteran .</brief_summary>
	<brief_title>Behavioral Treatment Overactive Bladder Men</brief_title>
	<detailed_description>Overactive bladder ( OAB ) common bothersome condition manifest urgency , frequent urination , urge urinary incontinence , nocturia . Drug therapy oxybutynin tolterodine common approach treatment OAB VA Medical Center clinic standard care nationally . Although improves symptom OAB many patient , drug therapy often side effect , cause significant number patient discontinue therapy . Further , many symptom completely control , even patient medication . Therefore , need improve intervention common problem . Although behavioral treatment well-established treatment urge urinary incontinence frequency woman , control trial behavioral treatment symptom OAB men . The primary purpose project evaluate effectiveness behavioral treatment symptom OAB male veteran . The study two-site ( Birmingham Atlanta ) randomize clinical trial evaluate effect behavioral training compare standard ( drug ) treatment control condition . Subjects 143 men OAB manifest urgency frequent urination ( &gt; 8 void per day ) , without incontinence , without significant bladder outlet obstruction . Following run-in period patient treat alpha blocker empirically treat undetected obstruction , stratify severity presence urge incontinence randomize 8 week behavioral treatment drug therapy . The behavioral treatment comprehensive , behavioral training program , include pelvic floor muscle rehabilitation , self monitor bladder diary , teach urge suppression skill inhibit detrusor contraction , thus reduce urgency , frequency , incontinence , nocturia . Patients control group receive standard therapy consist individually titrate , extended-release oxybutynin , well-established pharmacologic agent state art drug delivery system low rate side effect . Bladder diary complete subject prior randomization follow last treatment session use calculate change frequency urination , well symptom overactive bladder , include report urgency , incontinence , nocturia . Secondary outcome measure include patient global rating satisfaction improvement , impact incontinence , American Urological Association ( AUA ) Symptom Index . The second purpose study examine combine behavioral drug therapy . Following post-treatment assessment , patient achieve satisfactory outcome either behavioral drug therapy alone cross second phase , receive combine treatment improve outcome much possible . This study yield important information related alternative treatment OAB male veteran . Though many clinician use drug therapy routinely treatment OAB , offer behavioral treatment pelvic floor muscle training problem . Thus , study potential alter standard care OAB men .</detailed_description>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Oxybutynin</mesh_term>
	<mesh_term>Mandelic Acids</mesh_term>
	<criteria>Male Communitydwelling Veteran Selfreported urgency Selfreported frequent urination Mean &gt; 8 void per 24hour day bladder diary Able come clinic Urologic surgery past 6 month Nonambulatory ( unless independent transfer skill ) Flow rate &lt; 5mL baseline &lt; 10mL/sec runin ( simple uroflowmetry ) Postvoid residual urine volume &gt; 250mL baseline &gt; 150mL runin ( bladder ultrasound ) Continual leakage Urinary tract infection ( growth &gt; 100,000 colony per ml urinary pathogen urine culture ) . May reconsider treatment negative culture . Fecal impaction Poorly control diabetes ( glycosylated hemoglobin &gt; 9 within last 3 month ) Hematuria microscopic examination absence infection Any unstable medical condition ( particularly : decompensated congestive heart failure , malignant arrhythmia , unstable angina ) Impaired mental status ( &lt; 24 Folstein 's MiniMental State Exam ) Narrow angle glaucoma Gastric retention ( medical history ) Hypersensitivity tamsulosin oxybutynin Current use anticholinergic agent detrusor instability . May reconsider 2week washout . If diuretic , dose stable least three month Sleep apnea , unless surgically correct</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Overactive bladder</keyword>
	<keyword>Behavioral treatment</keyword>
	<keyword>Drug therapy</keyword>
	<keyword>Lower urinary tract symptom</keyword>
	<keyword>Urinary incontinence</keyword>
	<keyword>Clinical trial</keyword>
</DOC>